Rational Design of Vaccines Against Hepatitis C Virus (U19 Clinical Trial Not Allowed)

forecasted

The National Institute of Allergy and Infectious Diseases intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications to participate in a consortium of Research Centers focused on designing, optimizing, evaluating, and developing broadly protective vaccines for hepatitis C virus (HCV) to enable the advancement of vaccine candidates into clinical evaluation. This NOFO will utilize the U19 activity code. Applications are not being solicited at this time. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. Investigators with expertise and insights into this area of HCV vaccine development are encouraged to begin to consider applying for this new NOFO. In addition, collaborative investigations will be encouraged, and these investigators should also begin considering applying for this NOFO.